- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VIR
Recent news which mentions VIR
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
GlaxoSmithKline Drops Research On Otilimab In COVID-19
October 27, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
From Benzinga
From Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
From Motley Fool
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 06, 2021
From Benzinga
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
54 Biggest Movers From Friday
October 04, 2021
From Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
From Benzinga
From MarketWatch
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sinking This Week
September 24, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
From Benzinga
Smart Investors Are Watching This Trend Right Now
September 16, 2021
From Motley Fool
Vir Biotechnology Earnings Perspective: Return On Capital Employed
September 06, 2021
Tickers
VIR
From Benzinga
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
From Motley Fool
From Benzinga
From Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
3 Vaccine Stocks for the Next Decade
August 09, 2021
From Motley Fool
Earnings Scheduled For August 5, 2021
August 05, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.